Are Therapeutic Human Mesenchymal Stromal Cells Compatible with Human Blood?
Guido Moll(Humboldt-Universität zu Berlin), Katarina Le Blanc(Karolinska University Hospital), Peetra U. Magnusson(Science for Life Laboratory), Yuji Teramura(University of Tsukuba), Kristina Nilsson‐Ekdahl(Uppsala University), Ida Rasmusson-Duprez(Uppsala University), Helena Lönnies(Karolinska University Hospital), Olle Korsgren(Uppsala University), Anne‐Marie Fors Connolly(Umeå University), Graciela Elgue(Uppsala University), Lillemor Funke(Uppsala University), Bo Nilsson(Uppsala University), Javier Sánchez(Uppsala University), Lena von Bahr(Karolinska University Hospital), Osama A. Hamad(Uppsala University), Olle Ringdén(Karolinska Institutet)
Cited by 371
Related Papers
A monoclonal antibody-defined antigen associated with gastrointestinal cancer is a ganglioside containing sialylated lacto-N-fucopentaose II.
|Journal of Biological Chemistry|1982|883
Immunobiology of Human Mesenchymal Stem Cells and Future Use in Hematopoietic Stem Cell Transplantation
|Biology of Blood and Marrow Transplantation|2005|481
Increasing Incidence of Chronic Graft-versus-Host Disease in Allogeneic Transplantation: A Report from the Center for International Blood and Marrow Transplant Research
|Biology of Blood and Marrow Transplantation|2014|435